3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
2
Neoplasms
2
Fallopian Tube Neoplasms
2
Uterine Neoplasms
1
Triple-negative Metastatic Breast Cancer
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Laryngeal Neoplasms
1
Glioblastoma
1
Colorectal Neoplasms
1
Chromosome 5q Deletion Syndrome
1
Carcinoma, Ovarian Epithelial
1
Carcinoma
1
Interventions
Carboplatin
44
Paclitaxel
41
Cyclophosphamide
21
Topotecan
19
Cisplatin
18
Peripheral Blood Stem Cell Transplantation
15
Filgrastim
15
Docetaxel
15
Gemcitabine
13
Bevacizumab
13
liposomal doxorubicin
11
Hyperthermic Intraperitoneal Chemotherapy
11
sargramostim
9
Therapeutics
8
Immunohistochemistry
8
Psychiatric Rehabilitation
7
Drug Therapy
7
Amifostine
7
pembrolizumab
6
olaparib
6
Taxes
6
Surveys and Questionnaires
6
Melphalan
6
Flow Cytometry
6
Early Intervention, Educational
6
Chemotherapy, Adjuvant
6
niraparib
5
denileukin diftitox
5
Surgical Procedures, Operative
5
Immunoenzyme Techniques
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Ovarian Epithelial
×
adavosertib
×
Clear all
NCT01164995
2023-09-07
M10MKO
The Netherlands Cancer Institute
Phase 2
Completed
24 enrolled